未登录

D

Débora Kristina Alves-Fernandes

Universidade de São Paulo

H指数:10

被引数:776

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients

IF7.7

2021-08-019

OAAI

Survivin modulation in the antimelanoma activity of prodiginines

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2020-12-0115

OAAI

In vivo antitumoral effect of 4-nerolidylcatechol (4-NC) in NRAS-mutant human melanoma

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2020-07-013

OAAI

ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC)

PHARMACOLOGICAL RESEARCH

IF10.5

2019-03-0113

OAAI

Targeting protein disulfide isomerase to overcome resistance to BRAF inhibitors in melanoma

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2018-11-012

PREAI

ER stress induced by 4-nerolidylcathecol (4-NC) promotes antitumor effects in BRAFi/MEKi sensitive and resistant melanoma models

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-01-010

PRE

Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells

PHARMACOLOGICAL RESEARCH

IF10.5

2017-11-0115

PREAI

Inhibition of proliferation and invasion in 2D and 3D models by 2-methoxyestradiol in human melanoma cells

PHARMACOLOGICAL RESEARCH

IF10.5

2017-05-0122

OAAI

Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells

IF7.3

2016-10-1775

OAAI

Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation

PHARMACOLOGICAL RESEARCH

IF10.5

2016-09-0175

OAAI

Targeting hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells

CANCER RESEARCH

IF16.6

2016-07-150

PRE